Publications

Association of Serum Sclerostin with Bone Sclerostin in Chronic Kidney Disease is Lost in Glucocorticoid Treated Patients
Boltenstål H, Qureshi Ar, Behets Gj, Lindholm B, Stenvinkel P, D'haese Pc, et al
Calcified tissue international 2019;104(2):214-223

Causes of death across categories of estimated glomerular filtration rate: The Stockholm CREAtinine Measurements (SCREAM) project
Runesson B, Qureshi Ar, Xu H, Gasparini A, Lindholm B, Barany P, et al
PloS one 2019;14(1):e0209440-

Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies
Chronic Kidney Dis Prognosis Conso, Chronic Kidney Dis Epidemiology Co, Coresh J, Heerspink Hl, Sang Yy, Matsushita K, et al
LANCET DIABETES & ENDOCRINOLOGY 2019;7(2):115-127

Circulating proteins as predictors of cardiovascular mortality in end-stage renal disease
Feldreich T, Nowak C, Fall T, Carlsson Ac, Carrero Jj, Ripsweden J, et al
Journal of nephrology 2019;32(1):111-119

Differences in association of lower bone mineral density with higher coronary calcification in female and male end-stage renal disease patients
Chen Z, Qureshi Ar, Brismar Tb, Ripsweden J, Haarhaus M, Barany P, et al
BMC nephrology 2019;20(1):59-

Effects of acute fructose loading on levels of serum uric acid-a pilot study
Olofsson C, Anderstam B, Bragfors-helin Ac, Eriksson M, Qureshi Ar, Lindholm B, et al
European journal of clinical investigation 2019;49(1):e13040-

Skin autofluorescence, arterial stiffness and Framingham risk score as predictors of clinical outcome in chronic kidney disease patients: a cohort study
Mukai H, Svedberg O, Lindholm B, Dai L, Heimbürger O, Barany P, et al
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2019;34(3):442-448

Younger patients and smokers report a higher level of pain after knee arthroscopy: a clinical and experimental study including synovial metabolism
Berglund L, Stålman A, Dungner E, Qureshi Ar, Kumlin M, Felländer-tsai L
Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA 2019;27(2):471-477

Copeptin Plasma Levels are Associated with Decline of Renal Function in Patients with Type 2 Diabetes Mellitus
Villela-torres Ml, Higareda-mendoza Ae, Gómez-garcía A, Alvarez-paredes Ar, García-lópez E, Stenvikel P, et al
Archives of medical research 2018;49(1):36-43

Do metabolic derangements in end-stage polycystic kidney disease differ versus other primary kidney diseases?
Jankowska M, Qureshi Ar, Barany P, Heimburger O, Stenvinkel P, Lindholm B
Nephrology (Carlton, Vic.) 2018;23(1):31-36

Effects of Probiotic Supplementation on Trimethylamine-N-Oxide Plasma Levels in Hemodialysis Patients: a Pilot Study
Borges Na, Stenvinkel P, Bergman P, Qureshi Ar, Lindholm B, Moraes C, et al
Probiotics and antimicrobial proteins 2018;():-

Health-related quality of life in peritoneal dialysis patients: A narrative review
Aguiar R, Pei M, Qureshi Ar, Lindholm B
Seminars in dialysis 2018;():-

Inflammation down-regulates CYP3A4-catalysed drug metabolism in hemodialysis patients
Molanaei H, Qureshi Ar, Heimbürger O, Lindholm B, Diczfalusy U, Anderstam B, et al
BMC pharmacology & toxicology 2018;19(1):33-

Inverse J-shaped relation between coronary arterial calcium density and mortality in advanced chronic kidney disease
Mukai H, Dai L, Chen Z, Lindholm B, Ripsweden J, Brismar Tb, et al
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2018;():-

Lower serum calcium is independently associated with CKD progression
Janmaat Cj, Van Diepen M, Gasparini A, Evans M, Qureshi Ar, Ärnlöv J, et al
Scientific reports 2018;8(1):5148-

Lung Dysfunction and Mortality in Patients with Chronic Kidney Disease
Mukai H, Ming P, Lindholm B, Heimbürger O, Barany P, Stenvinkel P, et al
Kidney & blood pressure research 2018;43(2):522-535

New Algorithm for the Management of Orbital Blowout Fracture Based on Prospective Study
Alinasab B, Borstedt Kj, Rudström R, Ryott M, Qureshi Ar, Beckman Mo, et al
Craniomaxillofacial trauma & reconstruction 2018;11(4):285-295

Pregnancy-associated plasma protein-A predicts survival in end-stage renal disease-confounding and modifying effects of cardiovascular disease, body composition and inflammation
Nilsson E, Cao Y, Lindholm B, Ohyama A, Carrero Jj, Qureshi Ar, et al
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2018;33(6):971-977

Prospective Randomized Controlled Pilot Study on Orbital Blowout Fracture
Alinasab B, Borstedt Kj, Rudström R, Ryott M, Qureshi Ar, Stjärne P
Craniomaxillofacial trauma & reconstruction 2018;11(3):165-171

Restrictive lung disorder is common in patients with kidney failure and associates with protein-energy wasting, inflammation and cardiovascular disease
Mukai H, Ming P, Lindholm B, Heimbürger O, Barany P, Anderstam B, et al
PloS one 2018;13(4):e0195585-

Risk of hospitalization associated with body mass index and weight changes among prevalent haemodialysis patients
Cosmos Group, Carrero Jj, Cabezas-rodríguez I, Qureshi Ar, Floege J, Ketteler M, et al
Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 2018;38(5):520-527

Serum albumin, inflammation, and nutrition in end-stage renal disease: C-reactive protein is needed for optimal assessment
Mukai H, Villafuerte H, Qureshi Ar, Lindholm B, Stenvinkel P
Seminars in dialysis 2018;31(5):435-439

Serum Glutaredoxin Activity as a Marker of Oxidative Stress in Chronic Kidney Disease: A Pilot Study
Levin A, Nair D, Qureshi Ar, Bárány P, Heimburger O, Anderstam B, et al
Nephron 2018;140(4):249-256

The higher mortality associated with low serum albumin is dependent on systemic inflammation in end-stage kidney disease
Alves Fc, Sun J, Qureshi Ar, Dai L, Snaedal S, Bárány P, et al
PloS one 2018;13(1):e0190410-

Albuminuria changes are associated with subsequent risk of end-stage renal disease and mortality
Carrero Jj, Grams Me, Sang Y, Ärnlöv J, Gasparini A, Matsushita K, et al
Kidney international 2017;91(1):244-251

Bone mineral density of extremities is associated with coronary calcification and biopsy-verified vascular calcification in living-donor renal transplant recipients
Chen Z, Sun J, Haarhaus M, Barany P, Wennberg L, Ripsweden J, et al
Journal of bone and mineral metabolism 2017;35(5):536-543

CDKN2A/p16INK4a expression is associated with vascular progeria in chronic kidney disease
Stenvinkel P, Luttropp K, Mcguinness D, Witasp A, Qureshi Ar, Wernerson A, et al
Aging 2017;9(2):494-507

Clinical global assessment of nutritional status as predictor of mortality in chronic kidney disease patients
Dai L, Mukai H, Lindholm B, Heimbürger O, Barany P, Stenvinkel P, et al
PloS one 2017;12(12):e0186659-

Dialysis access, infections, and hospitalisations in unplanned dialysis start patients: results from the OPTiONS study
Machowska A, Alscher Md, Vanga Sr, Koch M, Aarup M, Qureshi Ar, et al
The International journal of artificial organs 2017;40(2):48-59

Does statins promote vascular calcification in chronic kidney disease?
Chen Z, Qureshi Ar, Parini P, Hurt-camejo E, Ripsweden J, Brismar Tb, et al
European journal of clinical investigation 2017;47(2):137-148

Incident elderly patients on peritoneal dialysis: Epidemiological characteristics and modality impact on survival time
Franco Mrg, Bastos Mg, Qureshi Ar, Schreider A, Bastos Ka, Divino-filho Jc, et al
Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia 2017;28(4):782-791

Initiation of erythropoiesis-stimulating agents and outcomes: a nationwide observational cohort study in anaemic chronic kidney disease patients
Evans M, Carrero Jj, Bellocco R, Barany P, Qureshi Ar, Seeberger A, et al
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2017;32(11):1892-1901

Low renal replacement therapy incidence among slowly progressing elderly chronic kidney disease patients referred to nephrology care: an observational study
Lundström Uh, Gasparini A, Bellocco R, Qureshi Ar, Carrero Jj, Evans M
BMC nephrology 2017;18(1):59-

Measures of chronic kidney disease and risk of incident peripheral artery disease: a collaborative meta-analysis of individual participant data
Chronic Kidney Disease Prognosis Consortium, Matsushita K, Ballew Sh, Coresh J, Arima H, Ärnlöv J, et al
The lancet. Diabetes & endocrinology 2017;5(9):718-728

Offering Patients Therapy Options in Unplanned Start (OPTiONS): Implementation of an educational program is feasible and effective
Machowska A, Alscher Md, Vanga Sr, Koch M, Aarup M, Qureshi Ar, et al
BMC nephrology 2017;18(1):18-

Plasma Beta-Trace Protein as a Marker of Residual Renal Function: The Effect of Different Hemodialysis Modalities and Intra-Individual Variability over Time
Van Craenenbroeck Ah, Bragfors-helin Ac, Qureshi Ar, Lindholm B, Sjöberg B, Anderstam B, et al
Kidney & blood pressure research 2017;42(5):877-885

Prospective study on ocular motility limitation due to orbital muscle entrapment or impingement associated with orbital wall fracture
Alinasab B, Qureshi Ar, Stjärne P
Injury 2017;48(7):1408-1416

Sclerostin─A Debutant on the Autosomal Dominant Polycystic Kidney Disease Scene?
Jankowska M, Haarhaus M, Qureshi Ar, Lindholm B, Evenepoel P, Stenvinkel P
Kidney international reports 2017;2(3):481-485

The impact of body mass index (BMI) variation on mortality of incident elderly patients on peritoneal dialysis: a joint model analysis
Franco Mrg, Colugnati Fab, Qureshi Ar, Divino-filho Jc, Fernandes Nmds
Jornal brasileiro de nefrologia : 'orgao oficial de Sociedades Brasileira e Latino-Americana de Nefrologia 2017;39(3):267-274

Time in Therapeutic Range and Outcomes After Warfarin Initiation in Newly Diagnosed Atrial Fibrillation Patients With Renal Dysfunction
Szummer K, Gasparini A, Eliasson S, Ärnlöv J, Qureshi Ar, Bárány P, et al
Journal of the American Heart Association 2017;6(3):-

Total and bone-specific alkaline phosphatase are associated with bone mineral density over time in end-stage renal disease patients starting dialysis
Bergman A, Qureshi Ar, Haarhaus M, Lindholm B, Barany P, Heimburger O, et al
Journal of nephrology 2017;30(2):255-262

Association between levels of pentraxin 3 and incidence of chronic kidney disease in the elderly
Sjöberg B, Qureshi Ar, Heimbürger O, Stenvinkel P, Lind L, Larsson A, et al
Journal of internal medicine 2016;279(2):173-9

Biomarkers of Cardiovascular Disease and Mortality Risk in Patients with Advanced CKD
Sun J, Axelsson J, Machowska A, Heimbürger O, Bárány P, Lindholm B, et al
Clinical journal of the American Society of Nephrology : CJASN 2016;11(7):1163-72

Circulating Alpha-Tocopherol and Insulin Sensitivity Among Older Men With Chronic Kidney Disease
Xu H, Xiong Z, Ärnlöv J, Qureshi Ar, Cederholm T, Sjögren P, et al
Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation 2016;26(3):177-82

C-reactive Protein: Repeated Measurements will Improve Dialysis Patient Care
Cobo G, Qureshi Ar, Lindholm B, Stenvinkel P
Seminars in dialysis 2016;29(1):7-14

Dialysis modality and nutritional status are associated with variability of inflammatory markers
Snaedal S, Qureshi Ar, Lund Sh, Germanis G, Hylander B, Heimbürger O, et al
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2016;31(8):1320-7

ELEVATED CIRCULATING S100A12 ASSOCIATES WITH VASCULAR DISEASE AND WORSE CLINICAL OUTCOME IN PERITONEAL DIALYSIS PATIENTS
Isoyama N, Machowska A, Qureshi Ar, Yamamoto T, Anderstam B, Heimburger O, et al
PERITONEAL DIALYSIS INTERNATIONAL 2016;36(3):269-76

Factors influencing access to education, decision making, and receipt of preferred dialysis modality in unplanned dialysis start patients
Machowska A, Alscher Md, Reddy Vanga S, Koch M, Aarup M, Qureshi Ar, et al
Patient preference and adherence 2016;10():2229-2237

Genotypic and phenotypic predictors of inflammation in patients with chronic kidney disease
Luttropp K, Debowska M, Lukaszuk T, Bobrowski L, Carrero Jj, Qureshi Ar, et al
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2016;31(12):2033-2040

Increased Telomere Attrition After Renal Transplantation-Impact of Antimetabolite Therapy
Luttropp K, Nordfors L, Mcguinness D, Wennberg L, Curley H, Quasim T, et al
Transplantation direct 2016;2(12):e116-

Plasma Pentosidine and Its Association with Mortality in Patients with Chronic Kidney Disease
Machowska A, Sun J, Qureshi Ar, Isoyama N, Leurs P, Anderstam B, et al
PloS one 2016;11(10):e0163826-

Prevalence and recognition of chronic kidney disease in Stockholm healthcare
Gasparini A, Evans M, Coresh J, Grams Me, Norin O, Qureshi Ar, et al
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2016;31(12):2086-2094

Serum Trimethylamine-N-Oxide Is Strongly Related to Renal Function and Predicts Outcome in Chronic Kidney Disease
Missailidis C, Hällqvist J, Qureshi Ar, Barany P, Heimbürger O, Lindholm B, et al
PloS one 2016;11(1):e0141738-

Telomere Attrition and Elongation after Chronic Dialysis Initiation in Patients with End-Stage Renal Disease
Kato S, Shiels Pg, Mcguinness D, Lindholm B, Stenvinkel P, Nordfors L, et al
BLOOD PURIFICATION 2016;41(1-3):25-33

The Stockholm CREAtinine Measurements (SCREAM) project: protocol overview and regional representativeness
Runesson B, Gasparini A, Qureshi Ar, Norin O, Evans M, Barany P, et al
Clinical kidney journal 2016;9(1):119-27

Trends in haemoglobin, erythropoietin-stimulating agents and iron use in Swedish chronic kidney disease patients between 2008 and 2013
Evans M, Suttorp Mm, Bellocco R, Hoekstra T, Qureshi Ar, Dekker Fw, et al
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2016;31(4):628-35

Type of Referral, Dialysis Start and Choice of Renal Replacement Therapy Modality in an International Integrated Care Setting
D.pd Clinics Eastern Europe, Marrón B, Ostrowski J, Török M, Timofte D, Orosz A, et al
PloS one 2016;11(5):e0155987-

Vertebral bone density associates with coronary artery calcification and is an independent predictor of poor outcome in end-stage renal disease patients
Chen Z, Qureshi Ar, Ripsweden J, Wennberg L, Heimburger O, Lindholm B, et al
Bone 2016;92():50-57

Associations between Thyroid Hormones, Calcification Inhibitor Levels and Vascular Calcification in End-Stage Renal Disease
Meuwese Cl, Olauson H, Qureshi Ar, Ripsweden J, Barany P, Vermeer C, et al
PloS one 2015;10(7):e0132353-

Cholinergic anti-inflammatory pathway activity in dialysis patients: a role for neuroimmunomodulation?
Hilderman M, Qureshi Ar, Al-abed Y, Abtahi F, Lindecrantz K, Anderstam B, et al
Clinical kidney journal 2015;8(5):599-605

Clinical determinants of reduced physical activity in hemodialysis and peritoneal dialysis patients
Cobo G, Gallar P, Gama-axelsson T, Di Gioia C, Qureshi Ar, Camacho R, et al
JOURNAL OF NEPHROLOGY 2015;28(4):503-10

Impact of Baseline Health-Related Quality of Life Scores on Survival of Incident Patients on Peritoneal Dialysis: A Cohort Study
Grincenkov Frd, Fernandes N, Pereira Bd, Bastos K, Lopes Aa, Finkelstein Fo, et al
NEPHRON 2015;129(2):97-103

Increased circulating sclerostin levels in end-stage renal disease predict biopsy-verified vascular medial calcification and coronary artery calcification
Qureshi Ar, Olauson H, Witasp A, Haarhaus M, Brandenburg V, Wernerson A, et al
KIDNEY INTERNATIONAL 2015;88(6):1356-1364

Increased Levels of Modified Advanced Oxidation Protein Products Are Associated with Central and Peripheral Blood Pressure in Peritoneal Dialysis Patients
Xu H, Cabezas-rodriguez I, Qureshi Ar, Heimburger O, Barany P, Snaedal S, et al
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis 2015;35(4):460-70

Nonesterified fatty acids and cardiovascular mortality in elderly men with CKD
Xiong Z, Xu H, Huang X, Ärnlöv J, Qureshi Ar, Cederholm T, et al
Clinical journal of the American Society of Nephrology : CJASN 2015;10(4):584-91

Oxidative DNA damage and mortality in hemodialysis and peritoneal dialysis patients
Xu H, Watanabe M, Qureshi Ar, Heimbürger O, Bárány P, Anderstam B, et al
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis 2015;35(2):206-15

Plasma S100A12 and soluble receptor of advanced glycation end product levels and mortality in chronic kidney disease Stage 5 patients
Isoyama N, Leurs P, Qureshi Ar, Bruchfeld A, Anderstam B, Heimburger O, et al
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2015;30(1):84-91

Serum hepatocyte growth factor is associated with truncal fat mass and increased mortality in chronic kidney disease stage 5 patients with protein-energy wasting
Yuan J, Watanabe M, Suliman M, Qureshi Ar, Axelsson J, Bárány P, et al
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2015;30(2):274-82

Uric acid is not associated with decline in renal function or time to renal replacement therapy initiation in a referred cohort of patients with Stage III, IV and V chronic kidney disease
Nacak H, Van Diepen M, Qureshi Ar, Carrero Jj, Stijnen T, Dekker Fw, et al
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2015;30(12):2039-45

Comparative associations of muscle mass and muscle strength with mortality in dialysis patients
Isoyama N, Qureshi Ar, Avesani Cm, Lindholm B, Bàràny P, Heimbürger O, et al
Clinical journal of the American Society of Nephrology : CJASN 2014;9(10):1720-8

Delta-He: a novel marker of inflammation predicting mortality and ESA response in peritoneal dialysis patients
Danielson K, Beshara S, Qureshi Ar, Heimbürger O, Lindholm B, Hansson M, et al
Clinical kidney journal 2014;7(3):275-81

Determinants of N-terminal pro-brain natriuretic peptide variation in hemodialysis patients and prediction of survival
Snaedal S, Qureshi Ar, Carrero Jj, Heimbürger O, Stenvinkel P, Bárány P
Blood purification 2014;37(2):138-45

Dialysis adequacy indices and body composition in male and female patients on peritoneal dialysis
Debowska M, Paniagua R, Ventura Md, Ávila-díaz M, Prado-uribe C, Mora C, et al
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis 2014;34(4):417-25

IGF-1 and survival in ESRD
Jia T, Gama Axelsson T, Heimbürger O, Bárány P, Lindholm B, Stenvinkel P, et al
Clinical journal of the American Society of Nephrology : CJASN 2014;9(1):120-7

Selection of genetic and phenotypic features associated with inflammatory status of patients on dialysis using relaxed linear separability method
Bobrowski L, Łukaszuk T, Lindholm B, Stenvinkel P, Heimburger O, Axelsson J, et al
PloS one 2014;9(1):e86630-

Three-month variation of plasma pentraxin 3 compared with C-reactive protein, albumin and homocysteine levels in haemodialysis patients
Sjöberg B, Snaedal S, Stenvinkel P, Qureshi Ar, Heimbürger O, Bárány P
Clinical kidney journal 2014;7(4):373-9

Validation of insulin sensitivity surrogate indices and prediction of clinical outcomes in individuals with and without impaired renal function
Jia T, Huang X, Qureshi Ar, Xu H, Ärnlöv J, Lindholm B, et al
Kidney international 2014;86(2):383-91

A BRAZILIAN EXPERIENCE IN ASSISTED AUTOMATED PERITONEAL DIALYSIS: A RELIABLE AND EFFECTIVE HOME CARE APPROACH
Franco Mrg, Fernandes N, Ribeiro Ca, Qureshi Ar, Divino Jc, Lima Mdg
PERITONEAL DIALYSIS INTERNATIONAL 2013;33(3):252-8

Association of Ethnicity and Survival in Peritoneal Dialysis: A Cohort Study of Incident Patients in Brazil
Fernandes Nmd, Hoekstra T, Van Den Beukel To, Tirapani L, Bastos K, Pecoits R, et al
AMERICAN JOURNAL OF KIDNEY DISEASES 2013;62(1):89-96

Body size and longitudinal body weight changes do not increase mortality in incident peritoneal dialysis patients of the Brazilian peritoneal dialysis multicenter study
Brazilian Peritoneal Dialysis Mult, Fernandes Nmd, Bastos Mg, Franco Mrg, Chaoubah A, Lima Md, et al
CLINICS 2013;68(1):51-8

Can Renal Nutrition Education Improve Adherence to a Low-Protein Diet in Patients With Stages 3 to 5 Chronic Kidney Disease?
Paes-barreto Jg, Silva Mib, Qureshi Ar, Bregman R, Cervante Vf, Carrero Jj, et al
JOURNAL OF RENAL NUTRITION 2013;23(3):164-71

Changes in circulating biomarkers during a single hemodialysis session
Yamamoto T, Nascimento Mm, Hayashi Sy, Qureshi Ar, Waniewski J, Brodin LÅ, et al
Hemodialysis international. International Symposium on Home Hemodialysis 2013;17(1):59-66

Circulating vascular endothelial growth factor (VEGF) and its soluble receptor 1 (sVEGFR-1) are associated with inflammation and mortality in incident dialysis patients
Yuan J, Guo Q, Qureshi Ar, Anderstam B, Eriksson M, Heimbürger O, et al
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2013;28(9):2356-63

Clinical determinants and mortality predictability of stearoyl-CoA desaturase-1 activity indices in dialysis patients
Huang X, Stenvinkel P, Qureshi Ar, Cederholm T, Bárány P, Heimbürger O, et al
Journal of internal medicine 2013;273(3):263-72

Determinants and survival implications of low bone mineral density in end-stage renal disease patients
Park Sh, Jia T, Qureshi Ar, Bárány P, Heimbürger O, Larsson Te, et al
Journal of nephrology 2013;26(3):485-94

Determinants of fibroblast growth factor-23 and parathyroid hormone variability in dialysis patients
Jia T, Qureshi Ar, Brandenburg V, Ketteler M, Barany P, Heimburger O, et al
American journal of nephrology 2013;37(5):462-71

Differences in acute metabolism of fructose between hemodialysis patients and healthy subjects
Anderstam B, Bragfors-helin Ac, Axelsson J, Qureshi Ar, Wibom R, Lindholm B, et al
Scandinavian journal of clinical and laboratory investigation 2013;73(2):154-60

Elevated circulating levels and tissue expression of pentraxin 3 in uremia: a reflection of endothelial dysfunction
Witasp A, Rydén M, Carrero Jj, Qureshi Ar, Nordfors L, Näslund E, et al
PloS one 2013;8(5):e63493-

Impaired postprandial fibroblast growth factor (FGF)-19 response in patients with stage 5 chronic kidney diseases is ameliorated following antioxidative therapy
Li M, Qureshi Ar, Ellis E, Axelsson J
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2013;28 Suppl 4():iv212-9

Increased risk of fatal infections in women starting peritoneal dialysis
Ros S, Remón C, Qureshi Ar, Quiros P, Lindholm B, Carrero Jj
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis 2013;33(5):487-94

Influence of Body Mass Index on the Association of Weight Changes with Mortality in Hemodialysis Patients
Cabezas-rodriguez I, Carrero Jj, Zoccali C, Qureshi Ar, Ketteler M, Floege J, et al
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY 2013;8(10):1725-33

LONGITUDINAL CHANGES IN HEALTH-RELATED QUALITY OF LIFE SCORES IN BRAZILIAN INCIDENT PERITONEAL DIALYSIS PATIENTS (BRAZPD): SOCIO-ECONOMIC STATUS NOT A BARRIER
Grincenkov Frd, Fernandes N, Chaoubah A, Fernandes Nd, Bastos K, Lopes Aa, et al
PERITONEAL DIALYSIS INTERNATIONAL 2013;33(6):687-96

Macrophage migration inhibitory factor (MIF) and thyroid hormone alterations in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV)
Wendt M, Börjesson O, Avik A, Bratt J, Anderstam B, Qureshi Ar, et al
Molecular medicine (Cambridge, Mass.) 2013;19():109-14

Metabolic changes in summer active and anuric hibernating free-ranging brown bears (Ursus arctos)
Stenvinkel P, Fröbert O, Anderstam B, Palm F, Eriksson M, Bragfors-helin Ac, et al
PloS one 2013;8(9):e72934-

Nonthyroidal illness: a risk factor for coronary calcification and arterial stiffness in patients undergoing peritoneal dialysis?
Meuwese Cl, Carrero Jj, Cabezas-rodríguez I, Heimburger O, Barany P, Lindholm B, et al
Journal of internal medicine 2013;274(6):584-93

Self-rated appetite as a predictor of mortality in patients with stage 5 chronic kidney disease
Gama-axelsson T, Lindholm B, Bárány P, Heimbürger O, Stenvinkel P, Qureshi Ar
Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation 2013;23(2):106-13

Study of the incidence of dialysis in Sao Paulo, the largest Brazilian city
Cordeiro Ac, Carrero Jj, Qureshi Ar, Da Cunha Rf, Lindholm B, De Castro I, et al
CLINICS 2013;68(6):760-5

Subclinical versus overt obesity in dialysis patients: more than meets the eye
Gracia-iguacel C, Qureshi Ar, Avesani Cm, Heimbürger O, Huang X, Lindholm B, et al
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2013;28 Suppl 4():iv175-81

The increase in renal replacement therapy (RRT) incidence has come to an end in Sweden-analysis of variations by region over the period 1991-2010
Qureshi Ar, Evans M, Stendahl M, Prütz Kg, Elinder Cg
Clinical kidney journal 2013;6(3):352-7

Visceral fat and coronary artery calcification in patients with chronic kidney disease
Cordeiro Ac, Qureshi Ar, Lindholm B, Amparo Fc, Tito-paladino A, Perini M, et al
NEPHROLOGY DIALYSIS TRANSPLANTATION 2013;:iv152-9

Baseline Levels and Trimestral Variation of Triiodothyronine and Thyroxine and Their Association with Mortality in Maintenance Hemodialysis Patients
Meuwese Cl, Dekker Fw, Lindholm B, Qureshi Ar, Heimburger O, Barany P, et al
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY 2012;7(1):131-8

Brazilian Peritoneal Dialysis Multicenter Study (BRAZPD): from conception to execution of a national peritoneal dialysis reality check
Divino-filho Jc, De Andrade Bastos K, Qureshi Ar, Riella Mc, Pecoits-filho R, Fernandes N
Contributions to nephrology 2012;178():23-9

Essential polyunsaturated fatty acids, inflammation and mortality in dialysis patients
Huang X, Stenvinkel P, Qureshi Ar, Risérus U, Cederholm T, Bárány P, et al
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2012;27(9):3615-20

FGF23, albuminuria, and disease progression in patients with chronic IgA nephropathy
Lundberg S, Qureshi Ar, Olivecrona S, Gunnarsson I, Jacobson Sh, Larsson Te
Clinical journal of the American Society of Nephrology : CJASN 2012;7(5):727-34

Lack of Adequate Predialyis Care and Previous Hemodialysis, but Not Hemoglobin Variability, Are Independent Predictors of Anemia-Associated Mortality in Incident Brazilian Peritoneal Dialysis Patients: Results from the BRAZPD Study
Brazpd Study Investigators, Goncalves Sm, Dal Lago Ea, De Moraes Tp, Kloster Sc, Boros G, et al
BLOOD PURIFICATION 2012;34(3-4):298-305

Metabolism of alprazolam (a marker of CYP3A4) in hemodialysis patients with persistent inflammation
Molanaei H, Stenvinkel P, Qureshi Ar, Carrero Jj, Heimbürger O, Lindholm B, et al
European journal of clinical pharmacology 2012;68(5):571-7

Pentraxin 3, a sensitive early marker of hemodialysis-induced inflammation
Sjöberg B, Qureshi Ar, Anderstam B, Alvestrand A, Bárány P
Blood purification 2012;34(3-4):290-7

Prolactin Levels, Endothelial Dysfunction, and the Risk of Cardiovascular Events and Mortality in Patients with CKD
Carrero Jj, Kyriazis J, Sonmez A, Tzanakis I, Qureshi Ar, Stenvinkel P, et al
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY 2012;7(2):207-15

Serum albumin as predictor of nutritional status in patients with ESRD
Gama-axelsson T, Heimbürger O, Stenvinkel P, Bárány P, Lindholm B, Qureshi Ar
Clinical journal of the American Society of Nephrology : CJASN 2012;7(9):1446-53

Testosterone deficiency is a cause of anaemia and reduced responsiveness to erythropoiesis-stimulating agents in men with chronic kidney disease
Carrero Jj, Barany P, Yilmaz Mi, Qureshi Ar, Sonmez A, Heimburger O, et al
NEPHROLOGY DIALYSIS TRANSPLANTATION 2012;27(2):709-15

Circulating Follistatin in Patients with Chronic Kidney Disease: Implications for Muscle Strength, Bone Mineral Density, Inflammation, and Survival
Miyamoto T, Carrero Jj, Qureshi Ar, Anderstarn B, Heimburger O, Barany P, et al
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY 2011;6(5):1001-8

Endogenous Testosterone, Endothelial Dysfunction, and Cardiovascular Events in Men with Nondialysis Chronic Kidney Disease
Yilmaz Mi, Sonmez A, Qureshi Ar, Saglam M, Stenvinkel P, Yaman H, et al
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY 2011;6(7):1617-25

Expression of osteoprotegerin in human fat tissue; implications for chronic kidney disease
Witasp A, Carrero Jj, Hammarqvist F, Qureshi Ar, Heimburger O, Schalling M, et al
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION 2011;41(5):498-506

Factors associated with the quality of life of incident patients on PD in Brazil (BRAZPD)
Grincenkov Fr, Fernandes N, Chaoubah A, Bastos K, Qureshi Ar, Pécoits-filho R, et al
Jornal brasileiro de nefrologia : 'orgao oficial de Sociedades Brasileira e Latino-Americana de Nefrologia 2011;33(1):38-44

Family Income and Survival in Brazilian Peritoneal Dialysis Multicenter Study Patients (BRAZPD): Time to Revisit a Myth?
Brazilian Peritoneal Dialysis Mult, Bastos Kd, Qureshi Ar, Lopes Aa, Femandes N, Barbosa Lmm, et al
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY 2011;6(7):1676-83

High-Mobility Group Box-1 Protein (HMGB1) Is Increased in Antineutrophilic Cytoplasmatic Antibody (ANCA)-Associated Vasculitis with Renal Manifestations
Bruchfeld A, Wendt M, Bratt J, Qureshi Ar, Chavan S, Tracey Kj, et al
MOLECULAR MEDICINE 2011;17(1-2):29-35

Influence of Erythropoiesis-Stimulating Agents on Glycated Hemoglobin in Nondiabetic Kidney Diseases at the Start of Dialysis
Cordeiro Ac, Carrero Jj, Barany P, Qureshi Ar, Heimburger O, Lindholm B, et al
AMERICAN JOURNAL OF NEPHROLOGY 2011;33(1):17-24

Inverse Relationship between the Inflammatory Marker Pentraxin-3, Fat Body Mass, and Abdominal Obesity in End-Stage Renal Disease
Miyamoto T, Qureshi Ar, Heimburger O, Barany P, Carrero K, Sjoberg B, et al
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY 2011;6(12):2785-91

Left Ventricular Hypertrophy in Incident Dialysis Patients Randomized to Treatment with Hemofiltration or Hemodialysis: Results from the ProFil Study
Profil Study Investigators, Alvestrand A, Ledebo I, Hagerman I, Wingren K, Mattsson E, et al
BLOOD PURIFICATION 2011;32(1):21-9

Macrophage MIF in ANCA-AAV
Bruchfeld A, Wendt M, Borjesson O, Avik A, Bratt J, Qureshi Ar, et al
CLINICAL AND EXPERIMENTAL IMMUNOLOGY 2011;:143-143

Plasma osteoprotegerin, arterial stiffness, and mortality in normoalbuminemic Japanese hemodialysis patients
Nakashima A, Carrero Jj, Qureshi Ar, Hirai T, Takasugi N, Ueno T, et al
OSTEOPOROSIS INTERNATIONAL 2011;22(6):1695-701

Postprandial metabolic response to a fat- and carbohydrate-rich meal in patients with chronic kidney disease
Miyamoto T, Qureshi Ar, Yamamoto T, Nakashima A, Lindholm B, Stenvinkel P, et al
NEPHROLOGY DIALYSIS TRANSPLANTATION 2011;26(7):2231-7

Prevalence and clinical implications of testosterone deficiency in men with end-stage renal disease
Carrero Jj, Qureshi Ar, Nakashima A, Arver S, Parini P, Lindholm B, et al
NEPHROLOGY DIALYSIS TRANSPLANTATION 2011;26(1):184-90

Protein-energy wasting modifies the association of ghrelin with inflammation, leptin, and mortality in hemodialysis patients
Carrero Jj, Nakashima A, Qureshi Ar, Lindholm B, Heimburger O, Barany P, et al
KIDNEY INTERNATIONAL 2011;79(7):749-56

Trimestral variations of C-reactive protein, interleukin-6 and tumour necrosis factor-alpha are similarly associated with survival in haemodialysis patients
Meuwese Cl, Snaedal S, Halbesma N, Stenvinkel P, Dekker Fw, Qureshi Ar, et al
NEPHROLOGY DIALYSIS TRANSPLANTATION 2011;26(4):1313-8

Uraemic sera stimulate lipolysis in human adipocytes: role of perilipin
Axelsson J, Astrom G, Sjolin E, Qureshi Ar, Lorente-cebrian S, Stenvinkel P, et al
NEPHROLOGY DIALYSIS TRANSPLANTATION 2011;26(8):2485-91

Abdominal fat deposition is associated with increased inflammation, protein-energy wasting and worse outcome in patients undergoing haemodialysis
Cordeiro Ac, Qureshi Ar, Stenvinkel P, Heimburger O, Axelsson J, Barany P, et al
NEPHROLOGY DIALYSIS TRANSPLANTATION 2010;25(2):562-8

Clinical importance of an elevated circulating chemerin level in incident dialysis patients
Yamamoto T, Qureshi Ar, Anderstam B, Heimburger O, Barany P, Lindholm B, et al
NEPHROLOGY DIALYSIS TRANSPLANTATION 2010;25(12):4017-23

Effect of Circulating Soluble Receptor for Advanced Glycation End Products (sRAGE) and the Proinflammatory RAGE Ligand (EN-RAGE, S100A12) on Mortality in Hemodialysis Patients
Nakashima A, Carrero Jj, Qureshi Ar, Miyamoto T, Anderstam B, Barany P, et al
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY 2010;5(12):2213-9

Predictors of Carotid Artery Intima-Media Thickness in Chronic Kidney Disease and Kidney Transplant Patients without Overt Cardiovascular Disease
Yilmaz Mi, Qureshi Ar, Carrero Jj, Saglam M, Suliman Me, Caglar K, et al
AMERICAN JOURNAL OF NEPHROLOGY 2010;31(3):214-21

Relation between serum fibroblast growth factor-23 level and mortality in incident dialysis patients: are gender and cardiovascular disease confounding the relationship?
Olauson H, Qureshi Ar, Miyamoto T, Barany P, Heimburger O, Lindholm B, et al
NEPHROLOGY DIALYSIS TRANSPLANTATION 2010;25(9):3033-8

Variations in C-reactive protein during a single haemodialysis session do not associate with mortality
Meuwese Cl, Halbesma N, Stenvinkel P, Dekker Fw, Molanaei H, Qureshi Ar, et al
NEPHROLOGY DIALYSIS TRANSPLANTATION 2010;25(11):3717-23

Whole blood cytokine attenuation by cholinergic agonists ex vivo and relationship to vagus nerve activity in rheumatoid arthritis
Bruchfeld A, Goldstein Rs, Chavan S, Patel Nb, Rosas-ballina M, Kohn N, et al
JOURNAL OF INTERNAL MEDICINE 2010;268(1):94-101

Visfatin is increased in chronic kidney disease patients with poor appetite and correlates negatively with fasting serum amino acids and triglyceride levels
Carrero Jj, Witasp A, Stenvinkel P, Qureshi Ar, Heimburger O, Barany P, et al
NEPHROLOGY DIALYSIS TRANSPLANTATION 2010;25(3):901-6

Vitamin D Deficiency in Dialysis Patients: Effect of Dialysis Modality and Implications on Outcome
Gracia-iguacel C, Gallar P, Qureshi Ar, Ortega O, Mon C, Ortiz M, et al
JOURNAL OF RENAL NUTRITION 2010;20(6):359-67

Vitamin D receptor gene, biochemical bone markers and bone mineral density in Mexican women on dialysis
Avila M, Prado C, Ventura Md, Mora C, Briones D, Valdez H, et al
NEPHROLOGY DIALYSIS TRANSPLANTATION 2010;25(7):2259-65

Additive Effects of Soluble TWEAK and Inflammation on Mortality in Hemodialysis Patients
Carrero Jj, Ortiz A, Qureshi Ar, Martin-ventura Jl, Barany P, Heimburger O, et al
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY 2009;4(1):110-8

Associations of VEGF and its receptors sVEGFR-1 and-2 with cardiovascular disease and survival in prevalent haemodialysis patients
Guo Qy, Carrero Jj, Yu Xq, Barany P, Qureshi Ar, Eriksson M, et al
NEPHROLOGY DIALYSIS TRANSPLANTATION 2009;24(11):3468-73

BICARBONATE-BASED PERITONEAL DIALYSIS SOLUTION HAS LESS EFFECT ON INGESTIVE BEHAVIOR THAN LACTATE-BASED PERITONEAL DIALYSIS SOLUTION
Zheng Zh, Anderstam B, Yu Xq, Qureshi Ar, Heimburger O, Lindholm B
PERITONEAL DIALYSIS INTERNATIONAL 2009;29(6):656-63

CCR5 Deletion Protects Against Inflammation-Associated Mortality in Dialysis Patients
Muntinghe Flh, Verduijn M, Zuurman Mw, Grootendorst Dc, Carrero Jj, Qureshi Ar, et al
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY 2009;20(7):1641-9

Comorbidity and Acute Clinical Events as Determinants of C-Reactive Protein Variation in Hemodialysis Patients: Implications for Patient Survival
Snaedal S, Heimburger O, Qureshi Ar, Danielsson A, Wikstrom B, Fellstrom B, et al
AMERICAN JOURNAL OF KIDNEY DISEASES 2009;53(6):1024-33

Elevated Serum Macrophage Migration Inhibitory Factor (MIF) Concentrations in Chronic Kidney Disease (CKD) Are Associated with Markers of Oxidative Stress and Endothelial Activation
Bruchfeld A, Carrero Jj, Qureshi Ar, Lindholm B, Barany P, Heimburger O, et al
MOLECULAR MEDICINE 2009;15(3-4):70-5

Elevated Visfatin/NAMPT Correlates with Anorexia and Reduced Fasting Serum Amino Acids in CKD Patients
Jesus Cj, Witasp A, Lindholm B, Nordfors L, Schalling M, Axelsson J, et al
BLOOD PURIFICATION 2009;28(4):318-318

High mobility group box protein-1 (HMGB-1) is increased in ANCA-associated vasculitis (AAV)
Bruchfeld A, Wendt M, Borjesson O, Bratt J, Qureshi Ar, Yang Lh, et al
APMIS 2009;:156-156

Inflammation modifies the association of osteoprotegerin with mortality in chronic kidney disease
Matsubara K, Stenvinkel P, Qureshi Ar, Carrero Jj, Axelsson J, Heimburger O, et al
JOURNAL OF NEPHROLOGY 2009;22(6):774-82

Low levels of IgM antibodies against phosphorylcholine-A increase mortality risk in patients undergoing haemodialysis
Carrero Jj, Hua X, Stenvinkel P, Qureshi Ar, Heimburger O, Barany P, et al
NEPHROLOGY DIALYSIS TRANSPLANTATION 2009;24(11):3454-60

Low Serum Testosterone Increases Mortality Risk among Male Dialysis Patients
Carrero Jj, Qureshi Ar, Parini P, Arver S, Lindholm B, Barany P, et al
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY 2009;20(3):613-20

Normalization of endothelial dysfunction following renal transplantation is accompanied by a reduction of circulating visfatin/NAMPT. A novel marker of endothelial damage?
Yilmaz Mi, Saglam M, Carrero Jj, Qureshi Ar, Caglar K, Eyileten T, et al
CLINICAL TRANSPLANTATION 2009;23(2):241-8

N-Terminal Pro-Brain Natriuretic Peptide Independently Predicts Protein Energy Wasting and Is Associated with All-Cause Mortality in Prevalent HD Patients
Guo Q, Barany P, Qureshi Ar, Snaedal S, Heimburger O, Stenvinkel P, et al
AMERICAN JOURNAL OF NEPHROLOGY 2009;29(6):516-23

Soluble CD14 Levels, Interleukin 6, and Mortality Among Prevalent Hemodialysis Patients
Raj Dsc, Carrero Jj, Shah Vo, Qureshi Ar, Barany P, Heimburger O, et al
AMERICAN JOURNAL OF KIDNEY DISEASES 2009;54(6):1072-80

Temporal discrepancies in the association between the apoB/apoA-I ratio and mortality in incident dialysis patients
Chmielewski M, Carrero Jj, Qureshi Ar, Axelsson J, Heimburger O, Berglund L, et al
JOURNAL OF INTERNAL MEDICINE 2009;265(6):708-16

Variations in graft and patient survival after kidney transplantation in Sweden: caveats in interpretation of center effects when benchmarking
Elinder Cg, Ekberg H, Barany P, Fehrman-ekholm I, Jensen G, Norden G, et al
TRANSPLANT INTERNATIONAL 2009;22(11):1051-7

ADMA levels correlate with proteinuria, secondary amyloidosis, and endothelial dysfunction
Yilmaz Mi, Sonmez A, Saglam M, Qureshi Ar, Carrero Jj, Caglar K, et al
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY 2008;19(2):388-95

Automated peritoneal dialysis as the modality of choice: a single-center, 3-year experience with 458 children in Mexico
Velasco Rf, Munoz Jl, Saavedra Vs, Trejo Jemb, Qureshi Ar, Garcia-lopez E, et al
PEDIATRIC NEPHROLOGY 2008;23(3):465-71

Bone mineral density in end-stage renal disease patients: Association with wasting, cardiovascular disease and mortality
Matsubara K, Suliman Me, Qureshi Ar, Axelsson J, Martola L, Heimburger O, et al
BLOOD PURIFICATION 2008;26(3):284-90

Consequences of low plasma histidine in chronic kidney disease patients: associations with inflammation, oxidative stress, and mortality
Watanabe M, Suliman Me, Qureshi Ar, Garcia-lopez E, Barany P, Heimburger O, et al
AMERICAN JOURNAL OF CLINICAL NUTRITION 2008;87(6):1860-6

Elevated serum levels of S-adenosylhomocysteine, but not homocysteine, are associated with cardiovascular disease in stage 5 chronic kidney disease patients
Valli A, Carrero Jj, Qureshi Ar, Garibotto G, Barany P, Axelsson J, et al
CLINICA CHIMICA ACTA 2008;395(1-2):106-10

Endogenous testosterone and mortality due to all-causes and cardiovascular disease in men undergoing hemodialysis
Carrero Jj, Qureshi Ar, Parini P, Arver S, Lindholm B, Barany P, et al
BLOOD PURIFICATION 2008;26(5):435-435

Endothelial dysfunction in type-2 diabetics with early diabetic nephropathy is associated with low circulating adiponectin
Yilmaz Mi, Saglam M, Qureshi Ar, Carrero Jj, Caglar K, Eyileten T, et al
NEPHROLOGY DIALYSIS TRANSPLANTATION 2008;23(5):1621-7

High mobility group box protein-1 correlates with renal function in chronic kidney disease (CKD)
Bruchfeld A, Qureshi Ar, Lindholm B, Barany P, Yang Lh, Stenvinkel P, et al
MOLECULAR MEDICINE 2008;14(3-4):109-15

Hyperinsulinemia and Insulin Resistance, Early Cardiovascular Risk Factors in Children with Chronic Kidney Disease
Lindblad Yt, Axelsson J, Barany P, Celsi G, Lindholm B, Qureshi Ar, et al
BLOOD PURIFICATION 2008;26(6):518-25

Is fetuin-A/alpha 2-Heremans-Schmid glycoprotein associated with the metabolic syndrome in patients with chronic kidney disease?
Axelsson J, Wang X, Ketteler M, Qureshi Ar, Heimburger O, Barany P, et al
AMERICAN JOURNAL OF NEPHROLOGY 2008;28(4):669-76

Lipoprotein Lipase 1595 C/G and Hepatic Lipase-480 C/T Polymorphisms - Impact on Lipid Profile in Incident Dialysis Patients
Chmielewski M, Stenvinkel P, Luttropp K, Suliman Me, Qureshi Ar, Carrero Jj, et al
BLOOD PURIFICATION 2008;26(6):555-60

Low serum fetuin-A concentration predicts poor outcome only in the presence of inflammation in prevalent haemodialysis patients
Metry G, Stenvinkel P, Qureshi Ar, Carrero Jj, Yilmaz Mi, Barany P, et al
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION 2008;38(11):804-11

Muscle atrophy, inflammation and clinical outcome in incident and prevalent dialysis patients
Carrero Jj, Axelsson J, Heimburger O, Barany P, Lindholm B, Stenvinkel P, et al
BLOOD PURIFICATION 2008;26(5):436-437

Muscle atrophy, inflammation and clinical outcome in incident and prevalent dialysis patients
Carrero Jj, Chmielewski M, Axelsson J, Snaedal S, Heimburger O, Barany P, et al
CLINICAL NUTRITION 2008;27(4):557-64

Novel links between the long pentraxin 3, endothelial dysfunction, and albuminuria in early and advanced chronic kidney disease
Suliman Me, Yimaz Mi, Carrero Jj, Qureshi Ar, Saglam M, Ipcioglu Om, et al
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY 2008;3(4):976-85

Serum visfatin concentration and endothelial dysfunction in chronic kidney disease
Yilmaz Mi, Saglam M, Carrero Jj, Qureshi Ar, Caglar K, Eyileten T, et al
NEPHROLOGY DIALYSIS TRANSPLANTATION 2008;23(3):959-65

Telomere attrition is associated with inflammation, low fetuin-A levels and high mortality in prevalent haemodialysis patients
Carrero Jj, Stenvinkel P, Fellstrom B, Qureshi Ar, Lamb K, Heimburger O, et al
JOURNAL OF INTERNAL MEDICINE 2008;263(3):302-12

The Brazilian peritoneal dialysis multicenter study (BRAZPD): Characterization of the cohort
Brazilian Peritoneal Dialysis Mul, Fernandes N, Bastos Mg, Cassi Hv, Machado Nl, Ribeiro Ja, et al
KIDNEY INTERNATIONAL 2008;:S145-51

The long pentraxin PTX-3 in prevalent hemodialysis patients: associations with comorbidities and mortality
Suliman Me, Qureshi Ar, Carrero Jj, Barany P, Yilmaz Mi, Snaedal-jonsdottir S, et al
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE 2008;101(5):397-405

Anti-endothelial cell autoantibodies selectively activate SAPK/JNK signalling in Wegener's granulomatosis
Holmen C, Elsheikh E, Christensson M, Liu J, Johansson As, Qureshi Ar, et al
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY 2007;18(9):2497-508

Association between tumor necrosis factor alpha (TNF) gene polymorphism and cardiovascular mortality in end-stage renal disease patients
Kato S, Axelsson J, Qureshi Ar, Yusawa Y, Maruyama Y, Barany P, et al
NEPHROLOGY DIALYSIS TRANSPLANTATION 2007;:311-311

Associations between the CYBA 242C/T and the MPO-463G/A polymorphisms, oxidative stress and cardiovascular disease in chronic kidney disease patients
Grahl Da, Axelsson J, Nordfors L, Heimburger O, Barany P, Qureshi Ar, et al
BLOOD PURIFICATION 2007;25(2):210-8

Changes in fat mass after initiation of maintenance dialysis is influenced by the uncoupling protein 2 exon 8 insertion/deletion polymorphism
Wang X, Axelsson J, Nordfors L, Qureshi Ar, Avesani C, Barany P, et al
NEPHROLOGY DIALYSIS TRANSPLANTATION 2007;22(1):196-202

Cholinergic anti-inflammatory pathway activity and high mobility group box-1 (HMGB1) serum levels in patients with rheumatoid arthritis
Goldstein Rs, Bruchfeld A, Yang L, Qureshi Ar, Gallowitsch-puerta M, Patel Nb, et al
MOLECULAR MEDICINE 2007;13(3-4):210-5

Circulating levels of Visfatin/Pre-B-Cell colony-enhancing factor 1 in relation to genotype,GFR, body composition, and survival in patients with CKD
Axelsson J, Witasp A, Carrero Jj, Qureshi Ar, Suliman Me, Heimburger O, et al
AMERICAN JOURNAL OF KIDNEY DISEASES 2007;49(2):237-44

Clinical and biochemical implications of low thyroid hormone levels (total and free forms) in CKD stage 5 patients
Carrero Jj, Qureshi Ar, Axelsson J, Barany P, Heimburger O, Alvestrand A, et al
NEPHROLOGY DIALYSIS TRANSPLANTATION 2007;:74-75

Clinical and biochemical implications of low thyroid hormone levels (total and free forms) in euthyroid patients with chronic kidney disease
Carrero Jj, Qureshi Ar, Axelsson J, Yilmaz Mi, Rehnmark S, Witt Mr, et al
JOURNAL OF INTERNAL MEDICINE 2007;262(6):690-701

Comparison of nutritional and inflammatory markers in dialysis patients with reduced appetites
Carrero Jj, Qureshi Ar, Axelsson J, Avesani Cm, Suliman Me, Kato S, et al
AMERICAN JOURNAL OF CLINICAL NUTRITION 2007;85(3):695-701

Endothelial dysfunction and visfatin levels before and after kidney transplantation
Yilmaz Mi, Axelsson J, Carrero Jj, Saglam M, Qureshi Ar, Caglar K, et al
NEPHROLOGY DIALYSIS TRANSPLANTATION 2007;:388-389

Gamma glutamyltranspeptidase activity and viral hepatitis in dialysis population
Fabrizi F, De Vecchi Af, Qureshi Ar, Aucella F, Lunghi G, Bruchfeld A, et al
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS 2007;30(1):6-15

Homocysteine and reverse epidemiology - Reply
Suliman Me, Stenvinkel P, Qureshi Ar, Kalantar-zadeh K, Lindholm B
NEPHROLOGY DIALYSIS TRANSPLANTATION 2007;22(7):2093-2093

Homocysteine-lowering is not a primary target for cardiovascular disease prevention in chronic kidney disease patients
Suliman Me, Lindholm B, Barany P, Qureshi Ar, Stenvinkel P
SEMINARS IN DIALYSIS 2007;20(6):523-9

Human liver sinusoidal endothelial cells induce apoptosis in activated T cells: a role in tolerance induction
Karrar A, Broome U, Uzunel M, Qureshi Ar, Sumitran-holgersson S
GUT 2007;56(2):243-52

Icodextrin metabolism and alpha-amylase activity in nonuremic rats undergoing chronic peritoneal dialysis
Garcia-lopez E, Pawlaczyk K, Anderstam B, Qureshi Ar, Kuzlan-pawlaczyk M, Heimburger O, et al
PERITONEAL DIALYSIS INTERNATIONAL 2007;27(4):415-23

Impact of inflammation on epigenetic DNA methylation - a novel risk factor for cardiovascular disease?
Stenvinkel P, Karimi M, Johansson S, Axelsson J, Suliman M, Lindholm B, et al
JOURNAL OF INTERNAL MEDICINE 2007;261(5):488-99

Obese sarcopenia in patients with end-stage renal disease is associated with inflammation and increased mortality
Honda H, Qureshi Ar, Axelsson J, Heimburger O, Suliman Me, Barany P, et al
AMERICAN JOURNAL OF CLINICAL NUTRITION 2007;86(3):633-8

Plasma pentraxin 3 in patients with chronic kidney disease: Associations with renal function, protein-energy wasting, cardiovascular disease, and mortality
Tong M, Carrero Jj, Qureshi Ar, Anderstam B, Heimburger O, Barany P, et al
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY 2007;2(5):889-97

S-adenosylhomocysteine levels are elevated and associated with cardiovascular disease in chronic kidney disease patients
Valli A, Carrero Jj, Suliman Me, Qureshi Ar, Garibotto G, Barany P, et al
NEPHROLOGY DIALYSIS TRANSPLANTATION 2007;:141-141

Serum long pentraxin 3 (PTX3) levels predict death in chronic kidney disease (CKD) patients independently of CRP values
Tong M, Carrero Jj, Suliman M, Qureshi Ar, Anderstam B, Axelsson J, et al
NEPHROLOGY DIALYSIS TRANSPLANTATION 2007;:140-141

Serum visfatin concentration and endothelial dysfunction in chronic kidney disease
Yilmaz Mi, Axelsson J, Carrero Jj, Saglam M, Qureshi Ar, Caglar K, et al
NEPHROLOGY DIALYSIS TRANSPLANTATION 2007;:5-5

Telomere shortening, a new mortality risk factor in dialysis patients. Associations with inflammatory markers and fetuin-a levels
Carrero Jj, Stenvinkel P, Fellstrom B, Qureshi Ar, Lamb K, Heimburger O, et al
BLOOD PURIFICATION 2007;25(4):338-338

The reverse epidemiology of plasma total homocysteine as a mortality risk factor is related to the impact of wasting and inflammation
Suliman M, Stenvinkel P, Qureshi Ar, Kalantar-zadeh K, Barany P, Heimburger O, et al
NEPHROLOGY DIALYSIS TRANSPLANTATION 2007;22(1):209-17

Are insulin-like growth factor and its binding proteins 1 and 3 clinically useful as markers of malnutrition, sarcopenia and inflammation in end-stage renal disease?
Axelsson J, Qureshi Ar, Divino Jc, Barany P, Heimburger O, Lindholm B, et al
EUROPEAN JOURNAL OF CLINICAL NUTRITION 2006;60(6):718-26

Changes in fat mass after initiation of maintenance dialysis is influenced by the uncoupling protein 2 Exon 8 insertion/deletion polymorphism
Axelsson J, Wang X, Nordfors L, Qureshi Ar, Avesani C, Barany P, et al
BLOOD PURIFICATION 2006;24(5-6):479-479

Changes in fat mass correlate with changes in soluble sCD163, a marker of mature macrophages, in patients with CKD
Axelsson J, Moller Hj, Witasp A, Qureshi Ar, Carrero Jj, Heimburger O, et al
AMERICAN JOURNAL OF KIDNEY DISEASES 2006;48(6):916-25

C-reactive protein variation and comorbidity in prevalent hemodialysis patients
Jonsdottir Ss, Barany P, Heimburger O, Qureshi Ar, Danielsson A, Fellstrom B, et al
NEPHROLOGY DIALYSIS TRANSPLANTATION 2006;:441-441

Elevated resistin levels in chronic kidney disease are associated with decreased glomerular filtration rate and inflammation, but not with insulin resistance
Axelsson J, Bergsten A, Qureshi Ar, Heimburger O, Barany P, Lonnqvist Fl, et al
KIDNEY INTERNATIONAL 2006;69(3):596-604

Hyperhomocysteinemia, malnutrition, and inflammation in ESRD patients
Suliman Me, Stenvinkel P, Barany P, Qureshi Ar, Lindholm B
SEMINARS IN NEPHROLOGY 2006;26(1):14-9

Inflammation and wasting in chronic kidney disease: Partners in crime
Avesani Cm, Carrero Jj, Axelsson J, Qureshi Ar, Lindholm B, Stenvinkel P
KIDNEY INTERNATIONAL 2006;:S8-S13

J-shaped mortality relationship for uric acid in CKD
Suliman Me, Johnson Rj, Garcia-lopez E, Qureshi Ar, Molinaei H, Carrero Jj, et al
AMERICAN JOURNAL OF KIDNEY DISEASES 2006;48(5):761-71

Plasma pentosidine and total homocysteine levels in relation to change in common carotid intima-media area in the first year of dialysis therapy
Suliman Me, Stenvinkel P, Jogestrand T, Maruyama Y, Qureshi Ar, Barany P, et al
CLINICAL NEPHROLOGY 2006;66(6):418-25

Serum albumin, C-reactive protein, interleukin 6, and fetuin A as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD
Honda H, Qureshi Ar, Heimburger O, Barany P, Wang K, Pecoits-filho R, et al
AMERICAN JOURNAL OF KIDNEY DISEASES 2006;47(1):139-48

Serum leptin and epoetin sensitivity - Reply
Axelsson J, Qureshi Ar, Heimburger O, Lindholm B, Stenvinkel P, Barany P
AMERICAN JOURNAL OF KIDNEY DISEASES 2006;47(2):372-372

Soluble adhesion molecules in end-stage renal disease: a predictor of outcome
Suliman Me, Qureshi Ar, Heimburger O, Lindholm B, Stenvinkel P
NEPHROLOGY DIALYSIS TRANSPLANTATION 2006;21(6):1603-10

Statin treatment and diabetes affect myeloperoxidase activity in maintenance hemodialysis patients
Stenvinkel P, Rodriguez-ayala E, Massy Za, Qureshi Ar, Barany P, Fellstrom B, et al
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY 2006;1(2):281-7

The osteoclast inhibitor osteoprotegerin is an independent predictor of survival in end-stage renal disease patients starting dialysis
Matsubara K, Anderstam B, Suliman M, Qureshi Ar, Axelsson J, Martola L, et al
NEPHROLOGY DIALYSIS TRANSPLANTATION 2006;:408-408

Toll like receptor 4 (TLR4) and tumor necrosis factor(TNF)-alpha genotypes influence mortality in end-stage renal disease (ESRD) patients
Kato S, Nordfors L, Axelsson J, Qureshi Ar, Yuzawa Y, Maruyama Y, et al
NEPHROLOGY DIALYSIS TRANSPLANTATION 2006;:127-127

Accelerated lean body mass loss in incident chronic dialysis patients with diabetes mellitus
Pupim Lb, Heimburger O, Qureshi Ar, Ikizler Ta, Stenvinkel P
KIDNEY INTERNATIONAL 2005;68(5):2368-74

Association between change in body composition and insertion/deletion polymorphism of uncoupling protein 2 in dialysis patients
Wang X, Stenvinkel P, Nordfors L, Heimburger O, Barany P, Qureshi Ar, et al
NEPHROLOGY DIALYSIS TRANSPLANTATION 2005;:V137-V137

Association between estrogen receptor alpha (ESRA) gene polymorphism and mortality in end-stage renal disease (ESRD) patients starting dialysis therapy
Kato S, Nordfors L, Stenvinkel P, Heimburger O, Qureshi Ar, Axelsson J, et al
NEPHROLOGY DIALYSIS TRANSPLANTATION 2005;:V78-V78

Body fat mass and serum leptin levels influence epoetin sensitivity in patients with ESRD
Axelsson J, Qureshi Ar, Heimburger O, Lindholm B, Stenvinkel P, Barany P
AMERICAN JOURNAL OF KIDNEY DISEASES 2005;46(4):628-34

Circulating inflammatory endothelial cells contribute to endothelial progenitor cell dysfunction in patients with vasculitis and kidney involvement
Holmen C, Elsheikh E, Stenvinkel P, Qureshi Ar, Pettersson E, Jalkanen S, et al
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY 2005;16(10):3110-20

Inflammation contributes to low plasma amino acid concentrations in patients with chronic kidney disease
Suliman Me, Qureshi Ar, Stenvinkel P, Pecoits R, Barany P, Heimburger O, et al
AMERICAN JOURNAL OF CLINICAL NUTRITION 2005;82(2):342-9

Insulin resistance and dyslipidemia in end-stage renal disease (ESRD) patients are influenced by the interleukin-18-137 G to C polymorphism
Honda H, Nordfors L, Qureshi Ar, Axelsson J, Schalling M, Sugisaki T, et al
NEPHROLOGY DIALYSIS TRANSPLANTATION 2005;:V309-V309

Low fetuin-A levels are associated with cardiovascular death: Impact of variations in the gene encoding fetuin
Stenvinkel P, Wang K, Qureshi Ar, Axelsson J, Pecoits R, Gao P, et al
KIDNEY INTERNATIONAL 2005;67(6):2383-92

Oxidative stress is associated with the insertion/deletion polymorphism in exon 8 of the uncoupling protein 2 gene in ESRD patients
Wang X, Stenvinkel P, Nordfors L, Axelsson J, Qureshi Ar, Barany P, et al
NEPHROLOGY DIALYSIS TRANSPLANTATION 2005;:V130-V130

Peroxisome proliferator-activated receptor gamma polymorphisms affect systemic inflammation and survival in end-stage renal disease patients starting renal replacement therapy
Yao Q, Nordfors L, Axelsson J, Heimburger O, Qureshi Ar, Barany P, et al
ATHEROSCLEROSIS 2005;182(1):105-11

The ACE intron 16 del/del genotype is associated with mortality and inflammation in ESRD patients
Watanabe M, Nordfors L, Axelsson J, Barany P, Heimburger O, Qureshi Ar, et al
NEPHROLOGY DIALYSIS TRANSPLANTATION 2005;:V312-V312

Endocannabinoid-independent retrograde signaling at inhibitory synapses in layer 2/3 of neocortex: Involvement of vesicular glutamate transporter 3
Harkany T, Holmgren C, Hartig W, Qureshi T, Chaudhry Fa, Storm-mathisen J, et al
JOURNAL OF NEUROSCIENCE 2004;24(21):4978-88

Hyperhomocysteinemia in relation to plasma free amino acids, biomarkers of inflammation and mortality in patients with chronic kidney disease starting dialysis therapy
Suliman Me, Stenvinkel P, Qureshi Ar, Barany P, Heimburger O, Anderstam B, et al
AMERICAN JOURNAL OF KIDNEY DISEASES 2004;44(3):455-65

Improvement of cardiac function after haemodialysis. Quantitative evaluation by colour tissue velocity imaging
Hayashi Sy, Brodin La, Alvestrand A, Lind B, Stenvinkel P, Do Nascimento Mm, et al
NEPHROLOGY DIALYSIS TRANSPLANTATION 2004;19(6):1497-506

Malnutrition and inflammation are associated with impaired pulmonary function in patients with chronic kidney disease
Nascimento Mm, Qureshi Ar, Stenvinkel P, Pecoits-filho R, Heimburger O, Cederholm T, et al
NEPHROLOGY DIALYSIS TRANSPLANTATION 2004;19(7):1823-8

The influence of hepatitis C and iron replacement therapy on plasma pentosidine levels in haemodialysis patients
Nascimento Mm, Suliman Me, Bruchfeld A, Hayashi Sy, Manfro Rc, Qureshi Ar, et al
NEPHROLOGY DIALYSIS TRANSPLANTATION 2004;19(12):3112-6

The prognostic impact of fluctuating levels of C-reactive protein in Brazilian haemodialysis patients: a prospective study
Nascimento Mm, Pecoits-filho R, Qureshi Ar, Hayashi Sy, Manfro Rc, Pachaly Ma, et al
NEPHROLOGY DIALYSIS TRANSPLANTATION 2004;19(11):2803-9

Truncal fat mass as a contributor to inflammation in end-stage renal disease
Axelsson J, Qureshi Ar, Suliman Me, Honda H, Pecoits-filho R, Heimburger O, et al
AMERICAN JOURNAL OF CLINICAL NUTRITION 2004;80(5):1222-9

Association between residual renal function inflammation and patient survival in new peritoneal dialysis patients
Chung Sh, Heimburger O, Stenvinkel P, Qureshi Ar, Lindholm B
NEPHROLOGY DIALYSIS TRANSPLANTATION 2003;18(3):590-7

Change in common carotid intima media thickness (CC IMT), in first year of dialysis therapy, is related to plasma pentosidine content.
Suliman Me, Stenvinkel P, Jogestrand T, Qureshi Ar, Barany P, Heimburger O, et al
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY 2003;:676A-677A

Chronic inflammation independently reduces plasma free amino acids (AA) in end-stage renal disease (ESRD) patients (pts).
Suliman Me, Pecoits R, Stenvinkel P, Qureshi Ar, Barany P, Heimburger O, et al
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY 2003;:529A-529A

C-reactive protein and interleukin-6 as biomarkers of systemic inflammation in end-stage renal disease.
Honda H, Qureshi Ar, Heimburger O, Pecoits-filho R, Stenvinkel P, Lindholm B
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY 2003;:718A-718A

Higher plasma total homocysteine (tHcy) level is associated with better survival in patients (pts) with end-stage renal disease (ESRD)
Suliman Me, Stenvinkel P, Qureshi Ar, Barany P, Heimburger O, Anderstam B, et al
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY 2003;:195A-195A

Plasma pentosidine is associated with inflammation and malnutrition in end-stage renal disease patients starting on dialysis therapy
Suliman Me, Heimburger O, Barany P, Anderstam B, Pecoits R, Ayala Er, et al
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY 2003;14(6):1614-22

Plasma total homocysteine (tHcy) is low in inflamed end-stage renal disease (ESRD) patients (pts)
Suliman Me, Stenvinkel P, Qureshi Ar, Barany P, Heimburger O, Anderstam B, et al
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY 2003;:194A-194A

Plasma total homocysteine (tHcy) is related to plasma free amino acids (AA) in end-stage renal disease (ESRD) patients (pts).
Suliman Me, Stenvinkel P, Qureshi Ar, Barany P, Heimburger O, Anderstam B, et al
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY 2003;:532A-532A

Twenty years experience of renal replacement rherapy: Patient survival with different modalities.
Qureshi Ar, Hylander B, Berglund J, Lindholm B, Elinder Cg
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY 2003;:499A-499A

European APD outcome study (EAPOS): Ultrafiltration and not solute clearance or solute transport status predicts outcomes at 2 years for APD in anuric patients.
Brown Ea, Davies Sj, Rutherford P, Riegel W, Frandsen Ne, Boras M, et al
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY 2002;:1A-1A

Heat sterilization of peritoneal dialysis solutions influences ingestive behavior in non-uremic rats
Zheng Zh, Anderstam B, Qureshi Ar, Heimburger O, Wang T, Sodersten P, et al
KIDNEY INTERNATIONAL 2002;62(4):1447-53

Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients
Qureshi Ar, Alvestrand A, Divino Jc, Gutierrez A, Heimburger O, Lindholm B, et al
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY 2002;13(1):S28-36

Influence of nutritional status on plasma and erythrocyte sulphur amino acids, sulph-hydryls, and inorganic sulphate in end-stage renal disease
Suliman Me, Barany P, Divino Jc, Qureshi Ar, Stenvinkel P, Heimburger O, et al
NEPHROLOGY DIALYSIS TRANSPLANTATION 2002;17(6):1050-6

Acute effects of peritoneal dialysis solutions on appetite in non-uremic rats
Zheng Zh, Sederholm F, Anderstam B, Qureshi Ar, Wang T, Sodersten P, et al
KIDNEY INTERNATIONAL 2001;60(6):2392-8

Hand-grip muscle strength, lean body mass, and plasma proteins as markers of nutritional status in patients with chronic renal failure close to start of dialysis therapy
Heimburger O, Qureshi Ar, Blaner Ws, Berglund L, Stenvinkel P
AMERICAN JOURNAL OF KIDNEY DISEASES 2000;36(6):1213-25

Hyperhomocysteinemia, nutritional status, and cardiovascular disease in hemodialysis patients
Suliman Me, Qureshi Ar, Barany P, Stenvinkel P, Divino Jc, Anderstam B, et al
KIDNEY INTERNATIONAL 2000;57(4):1727-35

Physiological saline is not a biocompatible peritoneal dialysis solution
Wang T, Heimburger O, Qureshi Ar, Waniewski J, Bergstrom J, Lindholm B
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS 1999;22(2):88-93

Factors predicting malnutrition in hemodialysis patients: A cross-sectional study
Qureshi Ar, Alvestrand A, Danielsson A, Divino Jc, Gutierrez A, Lindholm B, et al
KIDNEY INTERNATIONAL 1998;53(3):773-82

Daily exposure to dialysis fluid results in changes in peritoneal transport
Wang T, Qureshi Ar, Heimburger O, Waniewski J, Bergstrom J, Lindholm B
PERITONEAL DIALYSIS INTERNATIONAL 1997;17(4):379-86

Dioctyl sodium sulphosuccinate increases net ultrafiltration in peritoneal dialysis
Wang T, Qureshi Ar, Heimburger O, Waniewski J, Chen C, Bergstrom J, et al
NEPHROLOGY DIALYSIS TRANSPLANTATION 1997;12(6):1218-22

Daily exposure to dialysis fluid results in changes in peritoneal transport.
Wang T, Qureshi Ar, Heimburger O, Waniewski J, Bergstrom J, Lindholm B
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY 1996;7(9):A1272-A1272

Plasma total homocysteine is influenced by nutritional status in hemodialysis patients.
Suliman Me, Qureshi Ar, Anderstam B, Gutierrez A, Lindholm B, Bergstrom J
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY 1996;7(9):A0398-A0398

ELEVATED SERUM C-REACTIVE PROTEIN IS A STRONG PREDICTOR OF INCREASED MORTALT AND LOW SERUM ALBUM IN HEMODIALYSIS (HD) PATIENTS
Bergstrom J, Heimburger O, Lindholm B, Qureshi Ar
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY 1995;6(3):573-573

PREDICTORS OF MALNUTRITION IN MAINTENANCE HEMODIALYSIS (HD) PATIENTS
Qureshi Ar, Anderstam B, Danielsson A, Gutierrez A, Lindholm B, Bergstrom J
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY 1995;6(3):586-586

Show all publications